Back to news

Pfizer gains as investors focus on fresh pipeline updates and recent deal activity

Investivoq PriceTracker

Pfizer Inc. (PFE) is up 3.3% today. Here is some analysis on what might have caused this price movement.

Analysis: The clearest catalyst appears to be Pfizer’s October 14 pipeline update ahead of IDWeek 2026, which highlighted a broad set of infectious-disease data and several late-stage vaccine programs. The move may also be getting support from a newly announced research collaboration and a string of favorable early-October clinical updates, which together reinforce the view that investors are rewarding pipeline momentum.

Details:

  • Pfizer said it will present data from 57 abstracts at IDWeek 2026, including work tied to pneumococcal disease, RSV, COVID-19 and its Lyme vaccine candidate.
  • The company highlighted Phase 3 Lyme vaccine results, additional data for a next-generation pediatric pneumococcal vaccine candidate, and real-world evidence for marketed vaccines, giving investors several near- and medium-term readouts to watch.
  • Enodia Therapeutics announced on October 13 that it entered a research collaboration and license agreement with Pfizer focused on Sec61-targeting small molecules, adding another development signal around external innovation.
  • Earlier this month, Pfizer also reported positive Phase 3 vitiligo data for LITFULO, positive Phase 2 atopic dermatitis data for tilrekimig, and declared a fourth-quarter dividend of $0.43 per share.

    • Sources:

    Pfizer, Enodia Therapeutics, Yahoo Finance

    Disclaimer: This price movement analysis was generated with the help of AI. Please double-check the information provided for mistakes.

    $PFE Insider Trading Activity

    PFE Insider Trades

    $PFE insiders have traded $PFE stock on the open market 5 times in the past 6 months. Of those trades, 3 have been purchases and 2 have been sales.

    Here’s a breakdown of recent trading of $PFE stock by insiders over the last 6 months:

    • ALBERT BOURLA (Chairman & CEO) purchased 38,000 shares for an estimated $1,000,920
    • RONALD E BLAYLOCK purchased 39,231 shares for an estimated $998,821
    • MORTIMER J BUCKLEY purchased 37,632 shares for an estimated $960,368
    • JENNIFER B. DAMICO (SVP & Controller) has made 0 purchases and 2 sales selling 5,278 shares for an estimated $134,661.

    To track insider transactions, check out Investivoq's insider trading dashboard. You can access data on insider stock transactions through the Investivoq API insider transaction endpoint.

    EARLY ACCESS
    Receive PFE Data Alerts
    Real-time alerts on filings, insider trades, and market signals — before everyone else.
    Get Alerts →

    $PFE Hedge Fund Activity

    We have seen 1,301 institutional investors add shares of $PFE stock to their portfolio, and 1,402 decrease their positions in their most recent quarter.

    Here are some of the largest recent moves:

    • SIXTH STREET PARTNERS MANAGEMENT COMPANY, L.P. added 52,548,228 shares (+inf%) to their portfolio in Q2 2026, for an estimated $1,265,361,330
    • BLACKROCK, INC. added 31,412,883 shares (+6.3%) to their portfolio in Q2 2026, for an estimated $756,422,222
    • JPMORGAN CHASE & CO added 23,010,244 shares (+inf%) to their portfolio in Q2 2026, for an estimated $554,086,675
    • WELLINGTON MANAGEMENT GROUP LLP removed 22,090,883 shares (-44.3%) from their portfolio in Q2 2026, for an estimated $531,948,462
    • PACER ADVISORS, INC. added 16,793,903 shares (+inf%) to their portfolio in Q2 2026, for an estimated $404,397,184
    • MARSHALL WACE, LLP removed 15,280,392 shares (-95.0%) from their portfolio in Q2 2026, for an estimated $367,951,839
    • NORGES BANK removed 12,027,991 shares (-16.4%) from their portfolio in Q2 2026, for an estimated $289,634,023

    To track hedge funds' stock portfolios, check out Investivoq's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Investivoq API 13F endpoint.

    $PFE Government Contracts

    We have seen $1,093,616 of award payments to $PFE over the last year.

    Here are some of the awards which we have have seen pay out the most over the last year:

    • PFIZER VACCINES STORAGE AND ROTATION CONTRACT: $410,203
    • 4571812561!PROCARDIA XL 30 MG TABLET 100S: $24,729
    • 4571590545!NALOXONE 0.4 MG/ML VIALML: $22,620
    • 4571408600!PROCARDIA XL 30 MG TABLET 100S: $14,837

    To track government contracts to publicy traded companies, check out Investivoq's government contracts dashboard. You can access data on government contracts through the Investivoq API government contracts endpoint.

    $PFE Congressional Stock Trading

    Members of Congress have traded $PFE stock 1 times in the past 6 months. Of those trades, 0 have been purchases and 1 have been sales.

    Here’s a breakdown of recent trading of $PFE stock by members of Congress over the last 6 months:

    • SENATOR TOMMY TUBERVILLE sold up to $50,000 on 06/08.

    To track congressional stock trading, check out Investivoq's congressional trading dashboard. You can access data on congressional stock trades through the Investivoq API Congress trades endpoint.

    $PFE Price Targets

    Multiple analysts have issued price targets for $PFE recently. We have seen 5 analysts offer price targets for $PFE in the last 6 months, with a median target of $27.0.

    Here are some recent targets:

    • Chris Schott from JP Morgan set a target price of $28.0 on 07/08/2026
    • Rajesh Kumar from HSBC set a target price of $28.0 on 07/06/2026
    • Carter Gould from Cantor Fitzgerald set a target price of $27.0 on 07/06/2026
    • Trung Huynh from RBC Capital set a target price of $25.0 on 06/10/2026
    • Geoff Meacham from Citigroup set a target price of $27.0 on 04/29/2026

    This article is not financial advice. See Investivoq's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.